|
⚲
|
| Keyboard |
| Bruno Anthony D
✚
|
|
|---|---|
| CIK # | 0001374180 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001374180] | |
| 4 | [0001374180] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bruno Anthony D | |
| VYNE Therapeutics Inc | |
| Foamix Pharmaceuticals Ltd | |
| Warner Chilcott PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2024-12-12 | Grant | 20,000 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2024-01-01 | Grant | 20,000 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2023-12-13 | Grant | 20,000 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Options · derivative
|
2022-08-10 | Grant | 20,500 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Options · derivative
|
2021-07-19 | Grant | 20,500 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Stock Options · derivative
|
2020-08-03 | Grant | 22,500 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-04-03 | Grant | 14,933 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-04-03 | Grant | 75,690 | ||
|
VYNE Therapeutics Inc MNLO
Stock Option · derivative
|
2020-03-19 | Grant | 45,000 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-03-09 | Grant | 7,321 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-03-09 | Grant | 37,112 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-03-09 | Disposed to issuer | 62,647 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-03-09 | Disposed to issuer | 12,360 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-02-27 | Grant | 5,312 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2019-05-16 | Grant | 28,195 | $0.00 | |
|
Warner Chilcott PLC WCRX
Ordinary shares, par value $0.01 per share
|
2011-12-31 | Disposed to issuer | 61,512 | $0.00 |